text_1: 共有 298 例 患者 ( 26% ) 被 纳入 BRCA 突变 队列 ( 214 例 患者 [ 19% ] 有 生殖细胞 系 BRCA 突变 , 84 例 [ 7% ] 有 组织 BRCA 突变 ) , 627 例 患者 ( 55% ) 被 纳入 HRD 队列 ( 298 例 患者 [ 26% ] 有 HRD 肿瘤 并且 有 BRCA 突变 , 329 例 患者 [ 29% ] 有 HRD 肿瘤 但 无 BRCA 突变 ) .
  
text_2: a total of 298 patients ( 26 % ) were included in the BRCA @-@ mutation cohort ( 214 patients [ 19 % ] had a germline BRCA mutation , and 84 [ 7 % ] had a tissue @-@ based BRCA mutation ) , and 627 patients ( 55 % ) were included in the HRD cohort ( 298 patients [ 26 % ] had tumors that had HRD and were BRCA @-@ mutated , and 329 patients [ 29 % ] had tumors that had HRD with nonmutated BRCA ) .
  